Stable prevalence of chronic back disorders across gender, age, residence, and physical activity in Canadian adults from 2007 to 2014.
Adolescent
Adult
Age Distribution
Aged
Back Pain
/ epidemiology
Canada
/ epidemiology
Chronic Disease
Cross-Sectional Studies
Exercise
Female
Health Surveys
Humans
Longitudinal Studies
Male
Middle Aged
Nova Scotia
/ epidemiology
Prevalence
Quebec
/ epidemiology
Risk Factors
Rural Population
/ trends
Sex Distribution
Urban Population
/ trends
Young Adult
Back pain
Epidemiology
Joinpoint
Regression analysis
Spine
Trends
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
15 Aug 2019
15 Aug 2019
Historique:
received:
14
02
2019
accepted:
29
07
2019
entrez:
17
8
2019
pubmed:
17
8
2019
medline:
5
11
2019
Statut:
epublish
Résumé
Chronic back disorders (CBD) are a global health problem and the leading cause of years lived with disability. The present study aims to examine overall and specific trends in CBD in the Canadian population aged 18 to 65 years. Data from the Canadian Community Health Survey (CCHS), a cross-sectional study, from 2007 to 2014 (8 cycles) were used to calculate CBD prevalence across gender, age, geographical area (urban/rural and ten provinces and northern territories), and physical activity levels. CBD was defined in the CCHS as having back problems, excluding fibromyalgia and arthritis, which have lasted or are expected to last six months or more and that have been diagnosed by a health professional. Prevalence of CBD using survey weights and associated 95% confidence intervals (95% CI) were calculated yearly using balanced repeated replications technique. Trend tests were calculated using joinpoint regressions; ArcGIS software was used for mapping. Age-standardized CBD prevalence in 2007 and 2014 were 18.9% (95% CI = 18.4;19.5) and 17.8% (95% CI = 17.2,18.4), respectively. CBD prevalence was consistently higher in women, older age groups, rural dwellers, and people classified as inactive. Crude and age-standardized CBD prevalence decreased faster in people classified as physically active compared to those who were inactive (p < 0.006). Although CBD slightly decreased over time, no statistically significant trends were found overall or by gender, area of residence, province or level of physical activity. The prevalence of CBD remained consistently high in the province of Nova Scotia, and consistently low in the province of Quebec over the eight CCHS cycles. Despite prevention efforts, such as the Canadian back pain mass media campaign, CBD prevalence has remained stable between 2007 and 2014. Tailored prevention and management of CBD should consider gender, age, and geographical differences. Further longitudinal studies could elucidate the temporal relationship between potentially modifiable risk factors such as physical activity and CBD.
Sections du résumé
BACKGROUND
BACKGROUND
Chronic back disorders (CBD) are a global health problem and the leading cause of years lived with disability. The present study aims to examine overall and specific trends in CBD in the Canadian population aged 18 to 65 years.
METHODS
METHODS
Data from the Canadian Community Health Survey (CCHS), a cross-sectional study, from 2007 to 2014 (8 cycles) were used to calculate CBD prevalence across gender, age, geographical area (urban/rural and ten provinces and northern territories), and physical activity levels. CBD was defined in the CCHS as having back problems, excluding fibromyalgia and arthritis, which have lasted or are expected to last six months or more and that have been diagnosed by a health professional. Prevalence of CBD using survey weights and associated 95% confidence intervals (95% CI) were calculated yearly using balanced repeated replications technique. Trend tests were calculated using joinpoint regressions; ArcGIS software was used for mapping.
RESULTS
RESULTS
Age-standardized CBD prevalence in 2007 and 2014 were 18.9% (95% CI = 18.4;19.5) and 17.8% (95% CI = 17.2,18.4), respectively. CBD prevalence was consistently higher in women, older age groups, rural dwellers, and people classified as inactive. Crude and age-standardized CBD prevalence decreased faster in people classified as physically active compared to those who were inactive (p < 0.006). Although CBD slightly decreased over time, no statistically significant trends were found overall or by gender, area of residence, province or level of physical activity. The prevalence of CBD remained consistently high in the province of Nova Scotia, and consistently low in the province of Quebec over the eight CCHS cycles.
CONCLUSION
CONCLUSIONS
Despite prevention efforts, such as the Canadian back pain mass media campaign, CBD prevalence has remained stable between 2007 and 2014. Tailored prevention and management of CBD should consider gender, age, and geographical differences. Further longitudinal studies could elucidate the temporal relationship between potentially modifiable risk factors such as physical activity and CBD.
Identifiants
pubmed: 31416433
doi: 10.1186/s12889-019-7395-8
pii: 10.1186/s12889-019-7395-8
pmc: PMC6694571
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1121Subventions
Organisme : Canada Research Chairs
ID : 228136
Organisme : College of Medicine Graduate Award, University of Saskatchewan
ID : NA
Organisme : Founding Chairs Fellowship of the Canadian Centre for Health and Safety in Agriculture at the University of Saskatchewan
ID : NA
Références
Spine (Phila Pa 1976). 2004 Jan 1;29(1):70-7; discussion 77-8
pubmed: 14699279
Acta Orthop Scand Suppl. 1991;241:3-5
pubmed: 1826587
Clin Invest Med. 2009 Oct 01;32(5):E360-7
pubmed: 19796577
Arch Intern Med. 2009 Feb 9;169(3):251-8
pubmed: 19204216
J Phys Ther Sci. 2015 Dec;27(12):3851-4
pubmed: 26834367
Phys Ther. 2017 Apr 1;97(4):449-454
pubmed: 28339852
Bull World Health Organ. 2003;81(9):646-56
pubmed: 14710506
Spine (Phila Pa 1976). 2014 Nov 1;39(23):1960-8
pubmed: 25365711
Best Pract Res Clin Rheumatol. 2010 Dec;24(6):769-81
pubmed: 21665125
N Engl J Med. 1995 Feb 9;332(6):351-5
pubmed: 7823996
Physiother Can. 2015 Aug;67(3):221-31
pubmed: 26839448
Ann Rheum Dis. 2014 Jun;73(6):968-74
pubmed: 24665116
JAMA Intern Med. 2016 Feb;176(2):199-208
pubmed: 26752509
Healthcare (Basel). 2016 Apr 25;4(2):
pubmed: 27417610
Physiother Can. 2019 Summer;71(3):213-219
pubmed: 31719717
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Br J Anaesth. 2010 Dec;105 Suppl 1:i69-85
pubmed: 21148657
Rheumatology (Oxford). 2005 Jul;44(7):890-5
pubmed: 15784630
Eur Spine J. 2017 Sep;26(9):2467-2474
pubmed: 28776132
Scand J Med Sci Sports. 2001 Jun;11(3):178-84
pubmed: 11374432
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Spine (Phila Pa 1976). 2006 Jan 15;31(2):212-8
pubmed: 16418643
Eur J Public Health. 2007 Jun;17(3):318-22
pubmed: 16998207
Scand J Rheumatol. 1994;23(5):269-76
pubmed: 7973482
Med Sci Sports Exerc. 2002 Sep;34(9):1462-7
pubmed: 12218739
Addict Behav. 2010 Nov;35(11):1008-12
pubmed: 20621422
Br J Sports Med. 2017 Oct;51(19):1410-1418
pubmed: 28615218
J Manipulative Physiol Ther. 2005 Oct;28(8):555-63
pubmed: 16226622
Br J Sports Med. 2006 Feb;40(2):107-13
pubmed: 16431995
Occup Environ Med. 2009 Feb;66(2):137-9
pubmed: 19028803
Scand J Rheumatol. 1996;25(1):37-41
pubmed: 8774554
Biomed Res Int. 2014;2014:919621
pubmed: 24971357
Spine (Phila Pa 1976). 1998 Feb 1;23(3):371-7
pubmed: 9507628
J Phys Act Health. 2012 Jan;9 Suppl 1:S56-67
pubmed: 22287449
Spine (Phila Pa 1976). 2018 Aug;43(16):E935-E941
pubmed: 29462062
Physiology (Bethesda). 2015 Jan;30(1):8-16
pubmed: 25559151
BMJ. 2000 Jun 10;320(7249):1577-8
pubmed: 10845966
PLoS One. 2014 Sep 10;9(9):e107436
pubmed: 25207972
Curr Opin Rheumatol. 2005 Mar;17(2):134-40
pubmed: 15711224
Am J Epidemiol. 1998 Oct 1;148(7):671-82
pubmed: 9778174
Arthritis Rheum. 2008 Jan;58(1):15-25
pubmed: 18163481
Chronic Dis Inj Can. 2011 Sep;31(4):157-64
pubmed: 21978639
Eur J Public Health. 2016 Apr;26(2):248-53
pubmed: 26370439
Pain. 2017 Mar;158(3):369-370
pubmed: 28135214
Phys Ther. 2009 Jan;89(1):82-90
pubmed: 19008329
BMC Public Health. 2011 Feb 03;11:77
pubmed: 21291555
Pain. 2004 Jan;107(1-2):54-60
pubmed: 14715389